PT  - JOURNAL ARTICLE
AU  - Parpia, Alyssa S.
AU  - Pandey, Abhishek
AU  - Martinez, Isabel
AU  - El-Sayed, Abdulrahman M.
AU  - Wells, Chad R.
AU  - Myers, Lindsey
AU  - Duncan, Jeffrey
AU  - Collins, Jim
AU  - Fitzpatrick, Meagan C.
AU  - Galvani, Alison P.
TI  - Racial disparities in COVID-19 mortality across Michigan, United States
AID  - 10.1101/2020.11.30.20241133
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.30.20241133
4099  - http://medrxiv.org/content/early/2020/12/02/2020.11.30.20241133.short
4100  - http://medrxiv.org/content/early/2020/12/02/2020.11.30.20241133.full
AB  - Black populations in the US are disproportionately affected by the COVID-19 pandemic, but the increased mortality burden after accounting for health and demographic characteristics is not well understood. We evaluated COVID-19 mortality in Michigan using individual-level death certificate and surveillance data from the Michigan Department of Health and Human Services from March 16 to October 26, 2020. Among the 6,065 COVID-19-related deaths, Black individuals experienced 3.6 times the mortality rate as White individuals. Black individuals under 65 years without comorbidities had a mortality rate 12.6 times that of their White counterparts. After accounting for age, sex, and comorbidities, we found that Black individuals in all strata are at higher risk of COVID-19 mortality than their White peers. We demonstrate that inequities in mortality are driven by ongoing systemic racism, as opposed to comorbidity burden or older age, and further highlight how underlying disparities across the race are compounded in crises.Competing Interest StatementThe authors have declared no competing interest.Funding StatementASP, AP and APG were funded by NSF Expeditions grant 1918784, NIH grant 1R01AI151176-01, and NSF Rapid Response Research for COVID-19 grant RAPID-2027755. MCF was supported by NIH grant K01AI141576.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Yale IRB deemed the study as not Human Subjects research and as such, IRB approval was not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAggregated data are provided in the manuscript. Raw data may be requested from the Michigan Department of Health and Human Services.